Minovia Therapeutics Ltd, a clinical stage biopharmaceutical company advancing mitochondrial therapies for primary and secondary mitochondrial diseases, today announced that the U.S. Food and Drug ...

DOI: 10.1016/j.jmoldx.2024.01.011 FNU Alnoor et al, Deconvoluting the Complexity of Congenital Sideroblastic Anemias through Genetic and Functional Profiling, The Journal of Molecular Diagnostics ...

Aplastic anemia usually results in the immune system damaging bone marrow stem cells. Other potential causes include: medications exposure to toxins inherited genetic changes Aplastic anemia can ...

Patients have macrocytic sideroblastic anemia that is frequently transfusion-dependent and may be accompanied by thrombocytopenia and neutropenia. Pancreatic dysfunction occurs secondary to ...

Children living in poverty often suffer from anemia, a condition linked to serious health risks. A research team led by ...

Medical history has recently been made in a New York City hospital. This month, 21-year-old Sebastien Beauzile became the ...

Normocytic anemia is a type of anemia in which your red blood cells are normal in shape and size, but you don’t have enough circulating. It’s usually caused by an underlying health condition.

Anemia, affecting millions globally, occurs due to a lack of healthy red blood cells, leading to fatigue, weakness, and shortness of breath. Key signs include shortness of breath, hair loss, and ...

Sebastien Beauzile, 21, is the first New Yorker to have received the breakthrough Lyfgenia treatment, according to the New York Post.

HAIFA, Israel, April 03, 2025 (GLOBE NEWSWIRE) -- Minovia Therapeutics Ltd, a clinical stage biopharmaceutical company advancing mitochondrial therapies for primary and secondary mitochondrial ...